RheOx Registry Study in Europe

Last updated: March 21, 2022
Sponsor: Gala Therapeutics, Inc.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Chronic Bronchitis

Bronchitis

Copd (Chronic Obstructive Pulmonary Disease)

Treatment

N/A

Clinical Study ID

NCT04182841
CS005
  • All Genders

Study Summary

Post-market clinical study (registry study) to collect post-market safety and clinical utility data in European patients with chronic bronchitis treated with RheOx.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient has moderate to severe Chronic Bronchitis

Exclusion

Exclusion Criteria:

  • Patient has an implantable cardioverter defibrillator, pacemaker, or any otherimplantable electronic device.
  • Patient has history of ventricular tachyarrhythmia or any clinically significantatrial tachyarrhythmia (i.e., abnormality with vital signs) and/or history of type IIsecond or third degree AV block.
  • Patient has airway stent(s), valves, coils, or other lung implant/prosthesis.

Study Design

Total Participants: 100
Study Start date:
January 09, 2020
Estimated Completion Date:
December 15, 2025

Study Description

RheOx is a device-based, energy delivery system that delivers high frequency short duration energy to the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope.

Two sessions of treatment will be delivered one month apart. The right lung is treated at the first treatment session and the left lung is treated at the second treatment session (approximately one month after the right side is treated). Treatment will be delivered by a respiratory physician (interventional pulmonologist) in a tertiary teaching hospital during a bronchoscopic procedure. The bronchoscopy will be delivered during general anaesthesia. It is anticipated that the bronchoscopic procedure will last less than 60 minutes in total. Treatment will be deemed to have been delivered following the successful treatment during the two bronchoscopies.

Subjects will be required to submit to several tests and questionnaires during the study including respiratory function tests.

Connect with a study center

  • Otto Wagner Spital

    Wien, A-1140
    Austria

    Active - Recruiting

  • Pneumologie Thoraxklinik Heidelberg gGmbH University of Heidelberg

    Heidelberg, Baden-Württemberg 69047
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.